Hundreds of Florida’s biopharmaceutical, medical technology and health IT leaders will gather October 15 to 17 at The Vinoy Renaissance St. Petersburg Resort & Golf Club to celebrate the 20th anniversary of BioFlorida’s Annual Conference and Florida’s robust life sciences industry.

Join Occam Technology Group and other sponsors for two days filled with an informative program line up of scientific advancements, business achievements and public policy debates. The conference will host general sessions with prominent keynote speakers and 3 interactive tracks: BioScience, BioTrends and BioBusiness.

BioScience and BioTrends Breakout sessions address current topics in the industry and Florida’s areas of strengths including marine biotechnology, regenerative medicine, breakthrough research in oncology, and next generation technology with new sessions covering orphan drugs and rare diseases, and technology that bridges to the patient to improve care/treatment. BioBusiness Breakout Sessions recognize companies that have met significant milestones during the past year, and provide expert advice on commercialization, reimbursement, clinical trial strategy and design and financing options.

Ray Carr, founder and CTO of Occam Technology Group, will be moderating Diabetes: From Bench to Bedside on Monday, October 16, from 9:35 a.m to 10:50 a.m. This session includes panelists including Translational Research Institute for Metabolism and Diabetes investigator, Karen Corbin, and Dr. Michael Clare-Salzer, professor and chair of the University of Florida College of Medicine.

The program also includes the BioFlorida BioPitch Competition; awards recognizing and celebrating the most successful and growing companies, universities and research institutions in the state; and networking opportunities to connect with more than 400 professionals in the life sciences. For the full BioFlorida program and key note speakers visit


About BioFlorida

BioFlorida is the voice of Florida’s life science industry, representing nearly 6,000 establishments and research organizations in the biopharmaceutical, medical technology and bioagriculture sectors that collectively employ nearly 83,000 Floridians. [Source: The Value of Bioscience Innovation in Growing Jobs and Improving Quality of Life (TEConomy/BIO, 2016).

BioFlorida’s member driven initiatives provide a strong business climate for the advancement of innovative products that improve lives and promote economic benefits to the state.